Vanta Bioscience Ltd — Results, 29-05-2025: Result

Vanta Bioscience Limited has postponed its board meeting originally scheduled to approve the financial results for the half year and year ended March 31, 2025, due to a delay in receiving accounts from its associate company. This has impacted the preparation of consolidated financial results, pushing back their finalization. The revised meeting date will be communicated later. The trading window remains closed for designated persons until 48 hours after the board meeting concludes. This delay affects the timeline for the company’s audited financial disclosures.